Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunohistochemistry Single Marker With Interpretation Test

A specialized test using immunohistochemistry to detect specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tumor tissue sample, either in 10% Formal-saline or Formalin fixed paraffin embedded block.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Ensure the submitted tissue is properly labeled with patient information, site of biopsy, and relevant clinical history. A copy of the Histopathology report should accompany the sample.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Single Marker With Interpretation Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Cancer diagnosis confirmation
  • ✓Tumor subtyping
  • ✓Prognosis assessment
  • ✓Predicting treatment response
  • ✓Monitoring disease progression
  • ✓Identifying specific cancer markers
02

In plain language

What this test helps you understand

Aids in the diagnosis, classification, and prognosis of various cancers by identifying specific protein markers in tumor tissue. Helps guide personalized treatment decisions.
The Immunohistochemistry Single Marker With Interpretation Test is a diagnostic tool used primarily in oncology to analyze tumor tissues. This test uses immunohistochemical techniques to detect specific proteins (antigens) in tissue samples. Identifying these markers helps healthcare providers understand the type of cancer, its potential aggressiveness, and how it might respond to certain treatments. This information is crucial for oncologists and pathologists in assessing tumor characteristics and guiding personalized treatment strategies.

This test measures the presence and intensity of specific antigens within tumor cells using targeted antibodies. The results provide valuable insights into the tumor's biological profile.

This test is typically recommended for patients who have been diagnosed with cancer and require further characterization of their tumor, or for those whose symptoms or risk factors suggest a possible malignancy.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Ensure the submitted tissue is properly labeled with patient information, site of biopsy, and relevant clinical history. A copy of the Histopathology report should accompany the sample.
SampleTumor tissue sample, either in 10% Formal-saline or Formalin fixed paraffin embedded block.
MethodologyImmunohistochemistry (IHC) using specific antibodies to detect target antigens in tissue sections.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The test results depend on the quality of the tissue sample and the specific antibody used. Interpretation requires expertise from a pathologist. This test identifies a single marker; multiple markers may be needed for a complete picture.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunohistochemistry (IHC) is a laboratory technique that uses antibodies to detect specific proteins (antigens) in tissue samples. It helps identify characteristics of cells, such as the presence of cancer markers.
This test helps doctors confirm a cancer diagnosis, determine the specific type of cancer, understand its potential behavior, and guide treatment decisions based on the presence of specific markers.
A tissue sample from the tumor is required. This can be a formalin-fixed paraffin-embedded block or tissue in formalin-saline.
A pathologist interprets the results. It's important to discuss the findings with your doctor, who can explain what they mean for your specific situation and treatment plan.
No specific preparation is required from the patient for this test. The focus is on obtaining and preparing the correct tissue sample.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp